These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8270301)

  • 21. HCV infection and chronic active hepatitis in alcoholics.
    Brillanti S; Masci C; Siringo S; Di Febo G; Miglioli M; Barbara L
    Arch Virol Suppl; 1992; 4():212-4. PubMed ID: 1450689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon or corticosteroid: treatment of patients with chronic hepatitis C positive for serum markers of autoimmune diseases.
    Toda G
    Intern Med; 1997 Apr; 36(4):233-5. PubMed ID: 9187557
    [No Abstract]   [Full Text] [Related]  

  • 23. Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6.
    Vergani D; Mieli-Vergani G
    Clin Exp Immunol; 1993 Jun; 92(3):367-8. PubMed ID: 8390332
    [No Abstract]   [Full Text] [Related]  

  • 24. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease.
    Heintges T; Niederau C
    Z Gastroenterol; 1993 May; 31(5):285-8. PubMed ID: 7686702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized lichen planus associated with hepatitis C virus immunoreactivity.
    Bellman B; Reddy R; Falanga V
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):770-2. PubMed ID: 8912576
    [No Abstract]   [Full Text] [Related]  

  • 26. Sorting out the role of viral infections in autoimmune hepatitis.
    Roberts E
    J Pediatr Gastroenterol Nutr; 1993 Jan; 16(1):106-7. PubMed ID: 8433231
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmune responses as assessed by hypergammaglobulinemia and the presence of autoantibodies in patients with chronic hepatitis C.
    Kawamoto H; Sakaguchi K; Takaki A; Ogawa S; Tsuji T
    Acta Med Okayama; 1993 Oct; 47(5):305-10. PubMed ID: 8273454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic active hepatitis].
    Dhumeaux D
    Rev Prat; 1995 Dec; 45(20):2519-22. PubMed ID: 8578144
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus.
    Bianchi FB
    J Hepatol; 1993 Jul; 18(3):273-5. PubMed ID: 8228118
    [No Abstract]   [Full Text] [Related]  

  • 31. Serological definition of new subgroup of patients with autoimmune chronic active hepatitis.
    Stechemesser E; Strienz J; Berg PA
    Lancet; 1987 Mar; 1(8534):683. PubMed ID: 2882100
    [No Abstract]   [Full Text] [Related]  

  • 32. Sensory neuronopathy in autoimmune chronic active hepatitis.
    Merchut MP; Adams EM; Morrissey M
    Neurology; 1993 Nov; 43(11):2410-1. PubMed ID: 8232969
    [No Abstract]   [Full Text] [Related]  

  • 33. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is there a relationship between the presence of autoantibodies or mixed cryoglobulinemia and the clinical and histological characteristics of chronic viral hepatitis C?].
    Rolachon A; Pasquier D; Girard M; Arvieux J; Bichard P; Bensa JC; Zarski JP
    Gastroenterol Clin Biol; 1994; 18(3):251-6. PubMed ID: 7926441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis.
    Fusconi M; Lenzi M; Ballardini G; Miniero R; Cassani F; Zauli D; Bianchi FB
    Lancet; 1990 Sep; 336(8718):823. PubMed ID: 1976190
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic hepatitis C and autoimmunity: good response to immunosuppressive treatment.
    Tran A; Benzaken S; Yang G; Schneider S; Doglio A; Rampal A; Rampal P
    Dig Dis Sci; 1997 Apr; 42(4):778-80. PubMed ID: 9125648
    [No Abstract]   [Full Text] [Related]  

  • 37. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract]   [Full Text] [Related]  

  • 38. False positive reactivity for antibodies against hepatitis C virus in patients with autoimmune chronic active hepatitis?
    Schvarcz R; Weiland O; von Sydow M
    Scand J Infect Dis; 1990; 22(3):377-8. PubMed ID: 2115206
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chronic autoimmune hepatitis].
    Vaca Morales O; García-Tsao G
    Rev Gastroenterol Mex; 1988; 53(3):177-83. PubMed ID: 3057576
    [No Abstract]   [Full Text] [Related]  

  • 40. The natural course and heterogeneity of autoimmune-type chronic active hepatitis.
    Johnson PJ; McFarlane IG; Eddleston AL
    Semin Liver Dis; 1991 Aug; 11(3):187-96. PubMed ID: 1925643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.